Price Of Bharat Biotech's Intranasal Covid Vaccine

English News 28 Dec 2022 2

iNCOVACC vaccine will be rolled out in the country as a booster dose..

Bharat Biotech on Tuesday announced that iNCOVACC, the first-ever nasal COVID-19 vaccine will be rolled out in the country during the fourth week of January.

Bharat Biotech's nasal vaccine will be administered to only those above 18 years. In September, the Drugs Controller General of India approved iNCOVACC, the first COVID-19 nasal vaccine for restricted use in emergency situations for those above 18 years of age as a heterologous booster dose. 

The needleless vaccine is available on the CoWin portal, and the price has been set at Rs 800 for private markets and Rs 325 for supplies to the Government of India and state governments.

read more at republicworld

English News

Living in India